ERIC BRANDT - 02 May 2023 Form 4 Insider Report for DENTSPLY SIRONA Inc. (XRAY)

Role
Director
Signature
/s/ Dane Baumgardner, Attorney-In-Fact for Eric K. Brandt
Issuer symbol
XRAY
Transactions as of
02 May 2023
Transactions value $
-$4,340
Form type
4
Filing time
03 May 2023, 16:41:09 UTC
Previous filing
18 Apr 2023
Next filing
26 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction XRAY Common Stock Options Exercise $257,114 +6,200 +14% $41.47 51,102 02 May 2023 Direct
transaction XRAY Common Stock Sale -$261,454 -6,200 -12% $42.17 44,902 02 May 2023 Direct F1
holding XRAY Common Stock 5,400 02 May 2023 By The Brandt Family Trust U/a Dtd 06/09/2006

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction XRAY Stock Option (Right to Buy) Options Exercise $0 -6,200 -100% $0* 0 02 May 2023 Common Stock 6,200 $41.47 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on March 10, 2021, prior to the effectiveness of the revised requirements of Rule 10b5-1(c). In compliance with SEC guidance, the Reporting Person has not checked the box above but states that the Rule 10b5-1 trading plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
F2 This option is fully vested and exercisable.